Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:mental_disorder
|
| gptkbp:affects |
All Age Groups
|
| gptkbp:associatedWith |
Dysregulation of HPA Axis
Neurotransmitter Imbalance Serotonin Deficiency |
| gptkbp:canBe |
Moderate
Mild Severe |
| gptkbp:cause |
gptkb:Suicide
Impaired Social Functioning Increased Mortality |
| gptkbp:characterizedBy |
Impaired Functioning
Depressed Mood Loss of Interest |
| gptkbp:class |
gptkb:DSM-5
gptkb:ICD-10 |
| gptkbp:diagnosedBy |
Clinical Assessment
DSM-5 Criteria |
| gptkbp:firstDescribed |
19th Century
|
| gptkbp:includes |
gptkb:Premenstrual_Dysphoric_Disorder
gptkb:Major_Depressive_Disorder Disruptive Mood Dysregulation Disorder Persistent Depressive Disorder |
| gptkbp:mayInclude |
gptkb:Suicidal_Thoughts
Seasonal Fatigue Difficulty Concentrating Chronic Recurrent Sleep Disturbance Appetite Changes Feelings of Worthlessness Postpartum Single Episode |
| gptkbp:prevalence |
Common Worldwide
|
| gptkbp:relatedTo |
gptkb:Bipolar_Disorder
Anxiety Disorders |
| gptkbp:riskFactor |
gptkb:Trauma
Substance Abuse Chronic Stress Genetic Predisposition Medical Illness |
| gptkbp:studiedBy |
gptkb:Psychiatry
Clinical Psychology |
| gptkbp:symptomDuration |
At least 2 weeks (for Major Depressive Disorder)
|
| gptkbp:treatment |
gptkb:Cognitive_Behavioral_Therapy
gptkb:psychotherapy gptkb:Electroconvulsive_Therapy Antidepressant Medication |
| gptkbp:bfsParent |
gptkb:DSM-5-TR
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Depressive Disorders
|